Navigation Links
Acomplia Reduces Blood Sugar And Promotes Weight Loss

A six-month study named SERENADE (Study Evaluating Rimonabant Efficacy in Drug Naive Diabetic Patients) announced its findings// at the World Diabetes Congress in Cape Town. The study involved 278 patients with type 2 diabetes who were not taking any diabetic drugs.

Its major finding is : Acomplia (rimonabant) can significantly improve blood sugar levels in patients with type 2 diabetes while also helping them reduce their weight.

During the study, blood sugar levels of nearly half of the patients treated on Acomplia fell significantly-to below 7 percent -- and the patients on Acomplia lost around 15 pounds of weight when compared to 6 pounds of those on placebo.

"It is extraordinary that in this last group -- about 25 percent of the participants -- rimonabant was as efficient as several of the best anti-diabetic treatments," said Marc Cluzel, Head of International Development Scientific and Medical Affairs for Sanofi-Aventis.

About 9.4 percent on Acomplia left the trial midway due to adverse effects like dizziness, nausea, anxiety, depressed mood and headache compared to 2.1 percent on placebo.

Acomplia has already been approved as a diet pill in the European Union, Mexico and Argentina, but its release in the market has been withheld for months for reasons never disclosed by Sanofi-Aventis.
PRI
'"/>




Page: 1

Related medicine news :

1. Drug Reduces Risk of Clogged Arteries, Veins
2. Sunshine Reduces MS Risk
3. Estrogen in Food Reduces Cancer Risk
4. Dental Procedure Reduces Preterm Births
5. Vaccine Reduces antibiotic-resistant infections in Children
6. Eating Fiber Reduces The Risk Of Heart Disease
7. Higher Statin Dose Safely Reduces Stroke and Cardiac Arrest
8. Anti-tobacco Advertising Can Reduces smoking Among Teens
9. Eating Fish Reduces Heart Disease
10. Co-trimoxazole Use Reduces Childhood AIDS –Related Death
11. NSAIDS, Reduces The Risk Of Oral Cancer But Causes Heart Attacks
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2016)... SC (PRWEB) , ... May 27, 2016 , ... ... a line of classic American timber frame barn kits, which can be found on ... are inspired by historic American barn plans, and they highlight the craftsmanship of timber ...
(Date:5/27/2016)... ... ... An influential resource amongst nurses and professionals in the health care world, ... of topics detailing why we appreciate nurses in so many different ways. From exclusive ... being in a major recession to one of the hottest growing professions in any ...
(Date:5/27/2016)... ... May 27, 2016 , ... An ... bolstered by inspiring human-interest stories, courtesy of awareness-driven celebrities and thought leaders. It ... leading advocates, associations and industry leaders such as Bioness. , As patients ...
(Date:5/27/2016)... , ... May 27, 2016 , ... ... installment is bolstered by inspiring human interest stories, courtesy of leaders in the ... and tech within the industry, from leading advocates and associations—namely Jones & Bartlett ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... the pharmaceutical, medical and food industries. Aside from its GMP accreditation, Validation Center ... proof of successfully certified products, services and staff. , Validation Center is ISO17025 ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... -- MedDay, a biotechnology company focused on the ... entitled "High doses of biotin in progressive multiple sclerosis: extension ... Professor Ayman Tourbah , Principal Investigator of the Phase ... of Neurology (EAN) in Copenhagen, Denmark . ... place on Sunday, 29 May 2016 from 14:45 to 16:15 ...
(Date:5/24/2016)... 2016 Niederländische Chirurgen haben ... es Ärzten erlaubt, ihre Expertise weltweit zu teilen ... Live Streaming mit einer Instant-Messaging-Funktion und der Möglichkeit, ... in Europa, Afrika, Asien und den ... Plattform registriert. Information und Weiterbildung   ...
(Date:5/24/2016)...   , Study met both ... superiority in , Excellent plus Good ... of the ascending colon   , ... today announced new positive data from the phase III MORA study ... 2 litre PEG with ascorbate. The study met both primary endpoints ...
Breaking Medicine Technology: